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Abstract Objective: To assess the 
effect of partial liquid ventilation 
with perfluorocarbons on 
hemodynamics and gas exchange in 
large pigs with induced acute lung 
injury (ALI). 
Design: Randomized, prospective, 
double-control, experimental study. 
Setting: Experimental intensive care 
unit of a university. 
Materials: Eighteen large pigs 
(50 _+ 5 kg body weight) with an 
average anterior posterior thoracic 
diameter of 24 cm and induced 
acute lung injury. 
Interventions: All animals were 
surfactant depleted by lung lavage 
to a PaO2 below 100 mmHg and 
randomized to receive either per- 
flubron (n = 6) or saline (n = 6) in 
five intratracheal doses of 5 ml/kg 
at 20-rain intervals, or no instilla- 
tion (n = 6). 
Measurements and results: In all 
animals heart rate, arterial pres- 
sures, pulmonary pressures, cardiac 
output and blood gases were re- 
corded at 20-rain intervals. There 
was no deleterious effect on any 
hemodynamic parameter in the 
perflubron group, whereas ystolic 
and mean pulmonary arterial pres- 
sure values showed a persistent 
decrease after the first 5 ml/kg of 
perflubron, from 48.7 _+ 14.1 to 
40.8 _+ 11.7 mmHg and from 
39.7 _+ 13.2 to 35.2 _+ 12.0 mmHg, 
respectively. Perflubron resulted in 
a significant (ANOVA P < 0.01), 
dose-dependent i crease in PaO2 
values from 86.3 _+ 22.4 to a max- 
imum of 342.4 _+ 59.4 mmHg at 
a dose of 25 ml/kg; the other groups 
showed no significant increase 
in P .O2.  
Conclusions: Tracheal instillation 
of perflubron in induced ALI results 
in a dose-dependent i crease in 
PaO2 and has no deleterious effect 
on hemodynamic parameters. 
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Introduction 
In 1966 Clark and Gollan demonstrated the ability of 
small mammals to remain alive while breathing oxy- 
genated perfluorocarbons (PFCs) [1]. Since then PFCs 
have been investigated extensively as an alternative 
means of respiratory support, and PFCs oxygenated 
outside the body have been used in the treatment of 
acute respiratory failure [2, 3]. In 1991 Fuhrman et al. 
[4] demonstrated the feasibility of applying liquid ven- 
tilation in healthy animals without he need for a spe- 
cialized liquid breathing system. This technique of in 
vivo bubble oxygenation, combining intratracheal 
PFC administration with conventional ventilation, 
brought he use of PFCs for liquid ventilation closer to 
clinical practice. Our group [5-7] successfully applied 
this technique using perfiubron in rabbits with induced 
acute lung injury (ALI); the result was improved gas 
exchange, with no effect on arterial blood pressure. 
This perflubron (perfluorooctyl bromide; Alliance 
Pharmaceutical, San Diego, Calif., USA) is a new 
generation of PFC with a low surface tension of 
18.1 dyne/cm, a specific gravity of 1.918 g/cm 3 at 25 °C, 
a vapor pressure of 3.6 torr at 20 °C and of 10.5 torr at 
37 °C, an oxygen solubility of 53 ml/100 ml, a CO2 
solubility of 210ml/100ml at 37°C and an atmo- 
spheric pressure of 1. 
As a result of PFC filling, pulmonary vascular com- 
pression might be present, with a resulting increase in 
pulmonary arterial pressure and a decrease in cardiac 
output [8-10]. The above-mentioned studies using 
PFCs to improve blood gases were performed in small 
animals. Based on the size of the animals used and 
therefore on the total weight of the PFCs used, the 
hydrostatic pressure of the PFCs did not result in 
pulmonary vascular compression. However, this effect 
might occur in larger animals, although no studies 
using partial liquid ventilation and based on this hy- 
pothesis have yet been reported. In order to reach high 
hydrostatic pressures, we investigated the hemo- 
dynamic effects of perflubron in large pigs in the supine 
position with induced ALI, whose thoracic anterior 
posterior diameter was about 24 cm. 
Materials and methods 
per rain). Muscle relaxation was achieved by a continuous infusion 
of pancuronium bromide (2.5 btg/kg per rain). During the whole 
experimentN period, all animals were in a supine position. They 
were tracheotomized, intubated with an 8.0-ram endotracbeal tube 
fitted with a Filtraflux heat-moisture exchanger with a built-in 
bacterial filter (ICHOR AB, Bromma, Sweden) and cannulated with 
a carotid artery catheter, a 5F pulmonary artery catheter 
(SP51055H Viggo-Spectramed, Wiltshire, England) and a central 
venous catheter. During animal preparation, volume-controlled 
ventilation was provided with a Servo 300 ventilator (Siemens, 
Solna, Sweden) set at: frequency 20 beats rain, inspiratory time 25%, 
pause time 10%, inspiratory rise time 5%, PEEP 5 cm H20 and 
100% oxygen. Minute ventilation was adjusted to obtain a PaCOz of 
40 +_ 3 mmHg. These ventilator settings were maintained during the 
entire study period. 
All animals were surfactant depleted according to Lachmann et 
al. [-ill by repeated lung lavage with warm saline (38 °C, 30 ml/kg) 
to reduce P,02 to below 100 mmHg. To perform the lavage, the 
animals were disconnected from the ventilator and saiine was instil- 
led via an open-bottle-tube connection to a point at which systemic 
pressure decreased and pulmonary arterial pressure increased 
significantly. The saline was removed from the lung by gravitational 
force, i.e. lowering the bottle. After each lavage, the animals were 
reconnected to the ventilator for at least 10min before the next 
lavage was performed. After 1 h of ventilation following the last 
lung lavage, all animals were randomized to receive ither perfiub- 
ron (n = 6) or saline (n = 6) in five intratracheal doses of 5 mI/kg 
at 20-rain intervals, or to receive no instillation (n = 6) (control 
group). After the animals were disconnected from the ventilator, 
perflubron and saline were administered intratracheally as a bolus 
over a period of 10 s; they were reconnected to the ventilator im- 
mediately thereafter. 
Measurements 
Systolic (SysAP), diastolic (DiaAP) and mean (MAP) arterial pres- 
sures, as well as systolic (SysPAP), diastolic (DiaPAP) and mean 
(MPAP} pulmonary arterial pressures, pulmonary wedge pressure 
(PWP) and central venous pressure (CVP), were recorded in all 
animals using Statham P23XL transducers (Spectramed, Oxnard, 
Calif.). Cardiac output (CO) was measured in triplicate using the 
thermodilution technique with a Sirecust 1280 monitor (Siemens, 
Danvers, Mass. USA), which also traced heart rate (HR) and all 
recorded pressures. This monitor was also used to calculate pulmon- 
ary (PVR) and systemic vascular esistance (SVR). Arterial and 
mixed venous amples were analyzed for blood gases, pH and mixed 
venous oxygen saturation (S¥O2) by conventional methods (ABL- 
505 OSM-3 combination, Radiometer, Copenhagen, Denmark, set 
to measure swine hemoglobin). This combination was used to calcu- 
late base excess (BE), intrapulmonary shunt (shunt), arterial oxygen 
content (C~O2), oxygen delivery (DO2) and anteriovenous oxygen 
content difference (C,_ vO2). All measurements were recorded prior 
to lung lavage and subsequently at 20-rain intervals (at 20 rain after 
each dose in the treated groups in order to reach a steady state). At 
the end of the study period, all animals were killed with an intracar- 
diac overdose of KC1. 
Animal preparation 
The protocol of this study was approved by the university's animal 
experimental committee. Anesthesia was induced in 18 female 
Yorkshire pigs (body weight 50 +_ 5 kg) with ketamine (10 mg/kg) 
and midazolam (0.5 mg/kg), and was mainlained with continuous 
infusions of ketamine (80 l-tg/kg per min) and midazolam (9 gg/kg 
Statistical analysis 
All statistical analyses on recorded ata were performed using the 
Instat 2.0 biostatistics package (GraphPad Software, San Diego, 
Calif., USA). All intra-group comparisons were made with ANOVA 
repeated measures. If ANOVA resulted in a P < 0.05, a Dunnett 
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post-test was performed. This post-test used the post-lavage data 
(dose = 0 ml/kg body weight) as control. A P value of 0.05 was 
regarded as significant. All data are reported as mean values • 
standard eviation (SD). 
Results 
All animals were comparable with regard to body 
weight and thoracic diameter. Before and after lung 
lavage, all were also comparable with regard to 
blood gases and hemodynamic data (P >0.05, 
ANOVA). An average of 4 + 1 lavages was needed to 
obtain a PaO2 below 100 mmHg after resumption of 
ventilation. Although CO before and after lavage was 
slightly lower in the control group than in the two 
treated groups, this difference was not statistically 
significant. All animals survived the study period. 
Table 1 gives all the data on the hemodynamic para- 
meters measured and calculated during the study; 
Table 2 gives all the data on the recorded gas exchange 
parameters. 
Hemodynamics (Table 1) 
Control group 
After lung lavage, HR in the control group showed 
a significant increase from 113.2 _+ 30.3 to 123.7 _+ 33.6 
beats/min (P < 0.05) and SysAP values increased 
from 121.0 _+ 27.6 to 139.3 _+ 14.0mmHg; there was 
no significant change in DiaAP, MAP or CO, 
whereas CVP values decreased from 8.5 _+3.1 to 
6.8 _+ 3.5 mmHg (P < 0.05). There was no significant 
change in PWP, PVR, SVR or pulmonary arterial 
pressures. 
Saline group 
Following the lavage procedure and subsequent 
saline instillation, HR increased from 104.2 _+ 7.5 to 
153.8 _+ 28.7 beats/rain (P < 0.01). There was no signif- 
icant change in arterial pressures and SysPAP, whereas 
DiaPAP and MPAP values increased from 30.5 _+ 8.4 
to 38.7_+ 7.3mmHg and from 37.7 _+ 6.9 to 
46.7 __ 5.6 mmHg, respectively. CO values increased 
from 5.0_+ 0.9 to 7.3 _+ 1.3 1/min (P < 0.01); CVP 
values, from 5.7 _+ 2.9 to 9.2 _+ 3.3 mmHg (P < 0.01); 
and PWP values, from 10.7 _+ 4.7 to 13.0 +_ 4.6 mmHg 
(P < 0.01). There was no significant change in PVR, 
whereas SVR values decreased from 1995.8 _+ 324 to 
1346.3 __ 261 dynes, s/cm s (P < 0.01). 
P erflubron group 
Following lung lavage and perflubron treatment, there 
were no statistically significant changes in HR, arterial 
pressures, CO, CVP, PVR or SVR. SysPAP and 
MPAP values decreased from 48.7_+ 14.1 to 
40.8 _+ 11.7 mmHg (P < 0.01) and from 39.7 + 13.2 to 
34.8 __ 11.3 mmHg (P < 0.01), respectively. There was 
an increase in PWP values from 11.2 _+4.4 to 
15.2 _+ 3.8 mmHg, resulting in a statistically significant 
difference (P < 0.05) at the 25 ml/kg body weight dose. 
Gas exchange parameters (Table 2) 
Control group 
In the post-lavage period, there were no significant 
changes in P~O2 or shunt; PCO2 increased from 
52.4_+ 10.7 to 62.0_+ 16.9mmHg (P < 0.01), with 
a subsequent decrease in pH from 7.34 _+ 0.05 to 
7.28 __. 0.09 (P < 0.01); and there was no statistically 
significant change in BE. SVO2 values increased over 
time from 48.8 • 18.4 to 51.9 • 13.3% (P < 0.05). 
Analysis of calculated gas exchange parameters C~O2, 
DaO2 and Ca_vO 2 showed no statistically significant 
changes. 
Saline group 
Saline instillation resulted in a statistically significant 
and immediate dose-dependent deterioration ofall gas 
exchange parameters (PaO2, PCO2,  pH, BE, SVO2, 
shunt, CaO2, DaO2 and Ca-vO2). 
Perflubron group 
Perflubron treatment resulted in a dose-dependent im- 
provement in the measured gas exchange parameters. 
PaO2 values increased from 86.5_+ 22.4 to 
342.1 ___ 59.4 mmHg (P < 0.01); at doses of 15,20 and 
25 ml/kg, this increase was significantly different from 
the immediate post-lavage PaO2 values. PCO2 values 
decreased from 60.4 +_ 19.9 to 53.3 _+ 15.7mmHg 
(P <0.01) and pH increased from 7.28 _+0.13 to 
7.34 _+ 0.11 (P < 0.01). BE values increased towards 
pre-lavage (healthy) values (i.e. 3.9 _+ 0.9 mmol/1), 
from -0.5_+2.8 to 1.5_+2.5mmol/1 (P<0.01). 
SVO2 values increased rapidly from 45.6_+8.5 
to 59.5 _+ 16.4% (P < 0.01), whereas shunt values 
decreased from 36.6 __ 17.8 to 14.2 _+ 3.1% 
(P < 0.01). C~O2 values increased from 11.7 _+ 1.5 to 
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13.9 _+ 2.0 ml/dl (P < 0.01), whereas there were no sig- 
nificant changes in DaO2 or Ca-vO2. 
Discussion 
Since the introduction of partial iquid ventilation, only 
reports describing the influence of PFCs on gas ex- 
change in small animals have appeared in the literature 
[5-7, 12, 13]. The results of the present study show that 
the use of perflubron for partial liquid ventilation in 
induced ALI is an easy and effective therapy for im- 
proving gas exchange in large animals, as well. Addi- 
tionally, this study shows that the use of perflubron did 
not result in any deleterious effect on the hemodynamic 
parameters measured. 
In the present study, in order to achieve high hydros- 
tatic pressures, we used pigs with an average thoracic 
anterior-posterior diameter of 24 cm; in a totally PFC- 
filled lung, this would result in an average hydrostatic 
pressure of 46 cmH20 at the basal lung regions, as the 
specific gravity of perflubron is 1.918 g/cm 3 at 25 ~ 
Perflubron instillation in these animals shows that 
the use of partial liquid ventilation does not result in 
statistically significant changes in arterial pressures, 
CO, PVR or SVR. Systolic and mean pulm. onary arte- 
rial pressures howed a decrease after administration 
of only 5 ml/kg body weight perflubron and remained 
low throughout he study period. PWP showed a 
dose-dependent i crease in both the perflubron- and 
saline-treated groups. This may be attributed to the 
weight of the fluid-filled lung on the heart, resulting 
in a reduction of the diastolic filling phase. On the 
other hand, a fluid-filled lung might interfere with zone 
3 conditions and therefore result in erroneous PWP 
readings. 
In the perflubron group, there was no significant 
dose-dependent effect on PVR. This may be attributed 
in part to a decrease in MPAP and to the small de- 
crease in CO, combined with the observed increase in 
PWP. However, an actual change in PVR cannot be 
excluded, and we speculate that this could result from 
the following interactions: with increasing doses of per- 
flubron, oxygenation improves, resulting in a dose- 
dependent decrease in hypoxic vasoconstriction; this, in 
turn, results in a decrease in PVR. However, this de- 
crease in PVR might be counteracted by a hydrostatic 
vascular compression due to the instillation of perflub- 
ron (because of its high specific gravity), leading to an 
increase in PVR. The amount of increase in PVR due to 
hydrostatic vascular compression might be smaller 
than expected, as in vivo bubble oxygenation i partial 
liquid ventilation, together with the fact that the lung is 
only partially fluid filled, prevents the formation of unin- 
terrupted vertical fluid columns. Therefore, the actual 
hydrostatic pressure will be "lower than expected, as 
a surface pressure is dependent on the height of the fluid 
column above it. This situation is different from that 
during total liquid ventilation, where the lung is totally 
filled with fluid. A few studies reported hemodynamic 
compromise during total liquid ventilation. The authors 
of these studies attributed this result o the filling of the 
lung with high-density PFCs [2,3]. The observed 
hemodynamic compromise in these total liquid ventila- 
tion studies is speculated to result from pulmonary vas- 
cular compression, which is caused by an increase in the 
alveolar hydrostatic pressure gradient [9], and/or 
through an impairment of CO via a decrease in right 
ventricular preload combined with an increase in right 
ventricular afterload [10]. One report showed that this 
hemodynamic compromise could be corrected by ad- 
equate intravascular fluid administration [10]. 
The induced-ALI model used in the present study 
results in a decrease in arterial oxygenation as a result 
of a surfactant-deficiency-induced end-expiratory col- 
lapse, and is comparable to the changes found in respi- 
ratory distress yndrome (RDS) [14-16]. The results of 
this study confirm the positive effect of perflubron on 
gas exchange, as arterial oxygenation showed a signifi- 
cant dose-dependent i crease and carbon dioxide elim- 
ination was significantly improved by perflubron treat- 
ment. This positive effect of partial liquid ventilation 
might be mediated through the prevention of end- 
expiratory collapse by the physical presence of PFC in 
the alveolus. Due to the high transport capabilities for 
02 and CO2, PFCs can maintain gas exchange through 
in vivo bubble oxygenation [4]. This high transport 
capability results in a high dissolved volume of 02 that 
continues to oxygenate he blood during the expiratory 
period, which in a normal pattern of breathing is two- 
thirds of the respiratory cycle. 
The fact that the study was performed in large 
animals and used a post-lavage waiting period of 1 h 
makes this model comparable to other models of ALI 
and shows that the improvement in gas exchange can 
also occur in flooded alveoli [17]. In the perflubron- 
treated group, SVO2 showed a dose-dependent im- 
provement, whereas CO, DO2 and Ca_vO 2 showed no 
statistically significant improvement. This could indi- 
cate a better balance of oxygen demand and availabil- 
ity, which is also indicated by the improvement in BE 
(see below). However, firm conclusions can not be 
drawn from these data. The same effect was observed in 
the control group, in which SVO2 improved over time. 
In contrast o the saline and control groups, the 
arterial pH in the perflubron-treated group showed 
972 
a statistically significant, dose-dependent i crease to- 
wards physiological values, as did the arterial BE, in- 
dicating that the metabolic acidosis observed by others 
[-6] did not occur in the present study. The fact that pH 
and BE improved in the perflubron group could be 
speculated to result from the adequate hemodynamic 
status (i.e. stable CO and DO2), preventing the devel- 
opment of lactic acidosis. 
Based on the promising results of the present study, 
further investigations should be directed towards clini- 
cal outcome as well as towards the financial benefits of 
this easy-to-administer and highly effective type of ven- 
tilatory support. 
In conclusion, this study demonstrates that (1) the 
use of perflubron for partial liquid ventilation does not 
lead to hemodynamic depression; (2) perftubron par- 
tial liquid ventilation is an efficacious method for opti- 
mizing gas exchange in induced ALI; and (3) the use of 
perflubron does not result in metabolic acidoses, but 
improves pH towards physiological values. 
AcknoMedgements We thank Mrs Laraine Visser-Isles for English 
language editing and Mr. Ari Kok t for his technical assistance. This 
research was supported inpart by the International Foundation for 
Clinically Oriented Research and by the Alliance Pharmaceutical 
Corporation, San Diego, Calif., USA. 
References 
1. Clark LC, Gollan F (1966) Survival of 
mammals breathing organic liquids 
equilibrated with oxygen at atmospheric 
pressure. Science 152:1755-1756 
2. Wolfson MR, Greenspan JS, Deoras 
KS, Rubenstein SD, Shaffer TH (1992) 
Comparison of gas and liquid ventila- 
tion: clinical, physiological, and his- 
tological correlates. J Appl Physiol 72: 
1024 103t 
3. Greenspan JS, Wolfson MR, Rubenstein 
D, Shaffer TH (1990) Liquid ventilation 
of human preterm neonates. J Pediatr 
117:106-111 
4. Fuhrman BP, Paczan P, Defrancisis 
M (1991) Perftuorocarbon-associated 
gas exchange. Crit Care Med 19: 
712-722 
5. Tiitiincti AS, Faithfull NS, Lachmann 
B (1993) Intratracheal perfluorocarbon 
administration combined with artificial 
ventilation i  experimental respiratory 
distress syndrome: dose-dependent 
improvement of gas exchange. Crit Care 
Med 21:962-969 
6. Tiitiinc/i AS, Faithfull NS, Lachmann 
B (1993) Comparison ofventilatory sup- 
port with intratracheal perfluorocarbon 
administration a d conventional mech- 
anical ventilation i animals with acute 
respiratory failure. Am Rev Respir Dis 
148:785-792 
7. Tfit/incii AS, Akpir K, Mulder P, Erd- 
mann W, Lachmann B (1993) Intrat- 
racheal perfluorocarbon administration 
as an aid in the ventilatory management 
of respiratory distress yndrome. Anes- 
thesiology 79:1083-1093 
8. Lowe CA, Tuma RF, Sivieri EM, Shaffer 
TH (1979) Liquid ventilation: cardio- 
vascular adjustments with secondary 
hyperlactatemia and acidosis. J Appl 
Physiol 47:1051 1057 
9. Lowe CA, Shaffer TH (t986) Pulmonary 
vascular resistance in the fluorocarbon- 
filled lung. J Appl Physiol 60:154-159 
10. Curtis SE, Fuhrman BP, Howland DF, 
DeFrancisis M, Motoyama EK (1991) 
Cardiac output during liquid (per- 
fluorocarbon) breathing in newbron 
piglets. Crit Care Med 19:225 230 
11. Lachmann B, Robertson B, Vogel J 
(1980) In vivo lung lavage as an experi- 
mental model of the respiratory distress 
syndrome. Acta Anaesth Scand 24: 
231 236 
12. Lowe Leach C, Fuhrman BP, Morin 
FC, Rath MR (1993) Perfluorocarbon- 
associated gas exchange (partial liquid 
ventilation) in respiratory distress yn- 
drome: a prospective, randomized, con- 
trolled study. Crit Care Med 21: 
1270-1278 
13. Nesti FD, Fuhrman BP, Steinhorn DM, 
Papo MC, Hernan LJ, Duffy LC, Fisher 
JE, Leach CL, Paczan PR, Burak BA 
(1994) Perfluorocarbon-associated gas 
exchange in gastric aspiration. Crit Care 
Med 22:1445 1452 
14. Petty TL, Reiss OK, Paul GW, Silvers 
GW, Elkins ND (1977) Characteristics 
of pulmonary surfactant in adult respir- 
atory distress yndrome associated with 
trauma nd shock. Am Rev Respir Dis 
115:531 536 
15. Hallman M, Spragg R, Harell JH, 
Moser KM, Gluck L (1982) Evidence of 
lung surfactant abnormality in respirat- 
ory failure. J Clin Invest 70:673 683 
16. Avery ME, Mead J (1959) Surface prop- 
erties in relation to atelectasis and hya- 
line membrane disease. Am J Dis Child 
97:517-523 
17. Nielsen JB, Sj6strand UH, Edgren EL, 
Lichtwarck-Ashoff M, Svensson BA 
(1991) An experimental study of differ- 
ent ventilatory modes in piglets in severe 
respiratory distress induced by surfac- 
tant depletion. Intensive Care Med 17: 
225-233 
